Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_075278f8ff930d22805dfb62029c3e29 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
filingDate |
2006-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2009-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce73b0ebc1fbf1c6860a4ffa07afdaf1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93c47cedac8c1751c45a13ec51afaebf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0048c5663bbed0e623cab719e3f7157 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33d582adb861b4b878c06d46c0d9737f |
publicationDate |
2009-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7601739-B2 |
titleOfInvention |
Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases |
abstract |
Compounds for the treatment of estrogen-receptor related maladies are provided. Compounds with anti-androgenic properties also are provided. In particular, the invention provides compounds that are tetrahydroquinoline phenylamide derivatives and are useful for the treatment of breast and prostate cancer, and osteoporosis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10787410-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8962654-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019062248-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9708305-B2 |
priorityDate |
2003-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |